A nurse in a mental health facility is reinforcing teaching to a newly licensed nurse about how to perform an Abnormal Involuntary Movement Scale (AIMS) test on a client. The charge nurse should identify that the AIMS test is used for which of the following conditions?

A. Opiate withdrawal: The Abnormal Involuntary Movement Scale (AIMS) test is not used to assess opiate withdrawal. Opiate withdrawal symptoms typically involve physical and psychological effects, such as anxiety, muscle aches, and gastrointestinal distress, which are evaluated using different assessment tools. B. Lithium toxicity: The AIMS test is not applicable for assessing lithium toxicity. Symptoms of lithium toxicity can include tremors, confusion, and gastrointestinal issues, but these require different assessment methods rather than the AIMS scale. C. Tardive dyskinesia: The AIMS test is specifically designed to evaluate and monitor involuntary movements associated with tardive dyskinesia, a potential side effect of long-term use of antipsychotic medications. This scale helps identify abnormal movements in clients and aids in managing their treatment effectively. D. Alcohol withdrawal: The AIMS test is not intended for assessing alcohol withdrawal. Alcohol withdrawal is typically evaluated using clinical scales that focus on symptoms such as tremors, sweating, agitation, and hallucinations, rather than the involuntary movements assessed by the AIMS test.